LP
PBYI icon

LMR Partners’s Puma Biotechnology PBYI Stock Holding History

LMR Partners’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,006
Closed -$58.3K – 1362
2024
Q1 		$58.3K Buy
+11,006
New +$59.3K ﹤0.01% 975
2022
Q4 		– Sell
-11,514
Closed -$27K – 1235
2022
Q3 		$27K Hold
11,514
– – ﹤0.01% 1143
2022
Q2 		$33K Buy
+11,514
New +$28.6K ﹤0.01% 1193
2016
Q1 		– Sell
-9,402
Closed -$737K – 413
2015
Q4 		$737K Buy
+9,402
New +$738K 0.24% 88
2015
Q2 		– Sell
-7,122
Closed -$1.68M – 588
2015
Q1 		$1.68M Sell
7,122
-69,697
-91% -$14.9M 0.23% 121
2014
Q4 		$14.5M Buy
76,819
+20,187
+36% +$4.48M 1.9% 9
2014
Q3 		$13.5M Buy
+56,632
New +$11.6M 1.08% 36

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return